Additionally, the value of our methylation-based model in predicting treatment response was explored in GBM and LGG patients in the TCGA database and plotted with KM curves, and the average methylation level of MAL2 cg1+cg7 was used in the following analysis. The gene discussed is MAL2; the disease is glioblastoma.